Retatrutide is a research-stage compound studied for GLP-1, GIP and glucagon receptor activity
Currently available GLP-1 receptor agonists in the UK include: For type 2 diabetes : semaglutide (Ozempic [injection], Rybelsus [oral tablet]), dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia) For weight management : semaglutide 2.4 mg (Wegovy) and liraglutide 3 mg (Saxenda) Most GLP-1 medications are administered via subcutaneous injection, with dosing frequencies ranging from daily to once weekly depending on the specific formulation
2023;9(2):e13129
Hernandez combines evidence-based metabolic medicine with pediatric endocrinology, nutrition, exercise physiology, behavioral health, and personalized lifestyle interventions to help children build healthier metabolism and lifelong wellness
Under hypoxic conditions, intracellular molecules including HIFs actively coordinate the body's adaptive responses to ROS [535]